DEA Releases Threat Report Showing Rise in Use of Dangerous Drugs - National Commission on Correctional Health Care
Search
Close this search box.
drug dealFeb 23, 2024

DEA Releases Threat Report Showing Rise in Use of Dangerous Drugs



The Drug Enforcement Agency has released a report for law enforcement highlighting enduring and emerging threats, especially in the area of illegal and dangerous drugs.

The report, State and Territory Report and Enduring and Emerging Threats (STREET), shows:

Enduring Threats:

  • Fentanyl is the primary driver behind the ongoing epidemic of overdose deaths in the United States.
  • Fentanyl is increasingly being mixed with other illicit drugs, including methamphetamine, heroin, and cocaine
  • Deaths from psychostimulants (primarily methamphetamine) have sharply increased in the past five years.

Emerging Threats:

  • Xylazine, a potent animal tranquilizer, is primarily added to fentanyl and other opioids to enhance their effects. It is also known as “tranq.”
  • Xylazine is not an opioid, so naloxone/Narcan does not reverse its effects. It is also not a controlled substance under the U.S. Controlled Substances Act (CSA).
  • Xylazine has been encountered in combination with fentanyl, but has also been detected in mixtures containing cocaine and heroin.
  • Nitazenes (2-benzylbenzimidazoles) are an emerging synthetic opioid group that can be more potent than fentanyl and poses an additional opioid threat to the United States.

Please visit DEA.gov for more information.

Related News

Q and A 680x510 1

Standards Q&A: Documenting Nonemergent Health Care Requests

What touchpoints should we document for nonemergent medical, dental, and mental health care requests?
CCHP 680x510 1

CCHP Program Continues to be a Pillar of Patient Care

Certified Correctional Health Professional status was attained by 82 individuals in the first quarter
old man blog

Care for Aging Patients in the Correctional Setting

NCCHC’s new position statement addresses the needs of the aging population.